| 1. |
|
|
| 2. |
- Mehta, Rohtesh S., et al.
(författare)
-
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
- 2019
-
Ingår i: Blood Advances. - : American Society of Hematology. - 2473-9529 .- 2473-9537. ; 3:9, s. 1441-1449
-
Tidskriftsartikel (refereegranskat)abstract
- We report graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) (a composite end point of survival without grade III-IV acute GVHD [aGVHD], systemic therapy-requiring chronic GVHD [cGVHD], or relapse) and cGVHD-free relapse-free survival (CRFS) among pediatric patients with acute leukemia (n = 1613) who underwent transplantation with 1 antigen-mismatched (7/8) bone marrow (BM; n = 172) or umbilical cord blood (UCB; n = 1441). Multivariate analysis was performed using Cox proportional hazards models. To account for multiple testing, P < .01 for the donor/graft variable was considered statistically significant. Clinical characteristics were similar between UCB and 7/8 BM recipients, because most had acute lymphoblastic leukemia (62%), 64% received total body irradiation-based conditioning, and 60% received anti-thymocyte globulin or alemtuzumab. Methotrexate-based GVHD prophylaxis was more common with 7/8 BM (79%) than with UCB (15%), in which mycophenolate mofetil was commonly used. The univariate estimates of GRFS and CRFS were 22% (95% confidence interval [CI], 16-29) and 27% (95% CI, 20-34), respectively, with 7/8 BM and 33% (95% CI, 31-36) and 38% (95% CI, 35-40), respectively, with UCB (P < .001). In multivariate analysis, 7/8 BM vs UCB had similar GRFS (hazard ratio [HR], 1.12; 95% CI, 0.87-1.45; P = .39), CRFS (HR, 1.06; 95% CI, 0.82-1.38; P = .66), overall survival (HR, 1.07; 95% CI, 0.80-1.44; P = .66), and relapse (HR, 1.44; 95% CI, 1.03-2.02; P = .03). However, the 7/8 BM group had a significantly higher risk for grade III-IV aGVHD (HR, 1.70; 95% CI, 1.16-2.48; P = .006) compared with the UCB group. UCB and 7/8 BM groups had similar outcomes, as measured by GRFS and CRFS. However, given the higher risk for grade III-IV aGVHD, UCB might be preferred for patients lacking matched donors.
|
|
| 3. |
- Nikiforow, Sarah, et al.
(författare)
-
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated.
- 2018
-
Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 103:10, s. 1708-1719
-
Tidskriftsartikel (refereegranskat)abstract
- Upper gastrointestinal acute graft-versus-host disease is reported in approximately 30% of hematopoietic stem cell transplant recipients developing acute graft-versus-host disease. Currently classified as Grade II in consensus criteria, upper gastrointestinal acute graft-versus-host disease is often treated with systemic immunosuppression. We reviewed the Center for International Blood and Marrow Transplant Research database to assess the prognostic implications of upper gastrointestinal acute graft-versus-host disease in isolation or with other acute graft-versus-host disease manifestations. 8567 adult recipients of myeloablative allogeneic hematopoietic stem cell transplant receiving T-cell replete grafts for acute leukemia, chronic myeloid leukemia or myelodysplastic syndrome between 2000 and 2012 were analyzed. 51% of transplants were from unrelated donors. Reported upper gastrointestinal acute graft-versus-host disease incidence was 12.1%; 2.7% of recipients had isolated upper gastrointestinal acute graft-versus-host disease, of whom 95% received systemic steroids. Patients with isolated upper gastrointestinal involvement had similar survival, disease-free survival, transplant-related mortality, and relapse as patients with Grades 0, I, or II acute graft-versus-host disease. Unrelated donor recipients with isolated upper gastrointestinal acute graft-versus-host disease had less subsequent chronic graft-versus-host disease than those with Grades I or II disease (P=0.016 and P=0.0004, respectively). Upper gastrointestinal involvement added no significant prognostic information when present in addition to other manifestations of Grades I or II acute graft-versus-host disease. If upper gastrointestinal symptoms were reclassified as Grade 0 or I, 425 of 2083 patients (20.4%) with Grade II disease would be downgraded, potentially impacting the interpretation of clinical trial outcomes. Defining upper gastrointestinal acute graft-versus-host disease as a Grade II entity, as it is currently diagnosed and treated, is not strongly supported by this analysis. The general approach to diagnosis, treatment and grading of upper gastrointestinal symptoms and their impact on subsequent acute graft-versus-host disease therapy warrants reevaluation.
|
|
| 4. |
- Behrend, Dirk, et al.
(författare)
-
Recent Progress in the VLBI2010 Development
- 2008
-
Ingår i: in Proceedings of the 2007 IAG General Assembly, Perugia, Italy, July 2-13, 2007, ed. M. Sideris, Springer. - Berlin, Heidelberg : Springer Berlin Heidelberg. - 0939-9585. - 9783540854258 ; 133:Part 5, s. 833-840
-
Konferensbidrag (refereegranskat)abstract
- From October 2003 to September 2005, the International VLBI Service for Geodesy and Astrometry (IVS) examined current and future requirements for geodetic VLBI, including all components from antennas to analysis. IVS Working Group 3 "VLBI 2010", which was tasked with this effort, concluded with recommendations for a new generation of VLBI systems. These recommendations were based on the goals of achieving 1mm measurement accuracy on global baselines, performing continuous measurements for time series of station positions and Earth orientation parameters, and reaching a turnaround time from measurement to initial geodetic results of less than 24 h. To realize these recommendations and goals, along with the need for low cost of construction and operation, requires a complete examination of all aspects of geodetic VLBI including equipment, processes, and observational strategies. Hence, in October 2005, the IVS VLBI2010 Committee (V2C) commenced work on defining the VLBI2010 system specifications. In this paper we give a summary of the recent progress of the VLBI2010 project. © Springer-Verlag Berlin Heidelberg 2009.
|
|
| 5. |
|
|
| 6. |
- Eriksson, David, 1982, et al.
(författare)
-
Continental hydrology loading observed by VLBI measurements
- 2014
-
Ingår i: Journal of Geodesy. - : Springer Science and Business Media LLC. - 0949-7714 .- 1432-1394. ; 88:7, s. 675-690
-
Tidskriftsartikel (refereegranskat)abstract
- Variations in continental water storage lead to loading deformation of the crust with typical peak-to-peak variations at very long baseline interferometry (VLBI) sites of 3-15 mm in the vertical component and 1-2 mm in the horizontal component. The hydrology signal at VLBI sites has annual and semi-annual components and clear interannual variations. We have calculated the hydrology loading series using mass loading distributions derived from the global land data assimilation system (GLDAS) hydrology model and alternatively from a global grid of equal-area gravity recovery and climate experiment (GRACE) mascons. In the analysis of the two weekly VLBI 24-h R1 and R4 network sessions from 2003 to 2010 the baseline length repeatabilities are reduced in 79 % (80 %) of baselines when GLDAS (GRACE) loading corrections are applied. Site vertical coordinate repeatabilities are reduced in about 80 % of the sites when either GLDAS or GRACE loading is used. In the horizontal components, reduction occurs in 70-80 % of the sites. Estimates of the annual site vertical amplitudes were reduced for 16 out of 18 sites if either loading series was applied. We estimated loading admittance factors for each site and found that the average admittances were 1.01 0.05 for GRACE and 1.39 0.07 for GLDAS. The standard deviations of the GRACE admittances and GLDAS admittances were 0.31 and 0.68, respectively. For sites that have been observed in a set of sufficiently temporally dense daily sessions, the average correlation between VLBI vertical monthly averaged series and GLDAS or GRACE loading series was 0.47 and 0.43, respectively.
|
|
| 7. |
- Heinkelmann, R., et al.
(författare)
-
VLBI-derived troposphere parameters during CONT08
- 2011
-
Ingår i: Journal of Geodesy. - : Springer Science and Business Media LLC. - 0949-7714 .- 1432-1394. ; 85:7, s. 377-393
-
Tidskriftsartikel (refereegranskat)abstract
- Time-series of zenith wet and total troposphere delays as well as north and east gradients are compared, and zenith total delays (ZTD) are combined on the level of parameter estimates. Input data sets are provided by ten Analysis Centers (ACs) of the International VLBI Service for Geodesy and Astrometry (IVS) for the CONT08 campaign (12-26 August 2008). The inconsistent usage of meteorological data and models, such as mapping functions, causes systematics among the ACs, and differing parameterizations and constraints add noise to the troposphere parameter estimates. The empirical standard deviation of ZTD among the ACs with regard to an unweighted mean is 4.6 mm. The ratio of the analysis noise to the observation noise assessed by the operator/software impact (OSI) model is about 2.5. These and other effects have to be accounted for to improve the intra-technique combination of VLBI-derived troposphere parameters. While the largest systematics caused by inconsistent usage of meteorological data can be avoided and the application of different mapping functions can be considered by applying empirical corrections, the noise has to be modeled in the stochastic model of intra-technique combination. The application of different stochastic models shows no significant effects on the combined parameters but results in different mean formal errors: the mean formal errors of the combined ZTD are 2.3 mm (unweighted), 4.4 mm (diagonal), 8.6 mm [variance component (VC) estimation], and 8.6 mm (operator/software impact, OSI). On the one hand, the OSI model, i.e. the inclusion of off-diagonal elements in the cofactor-matrix, considers the reapplication of observations yielding a factor of about two for mean formal errors as compared to the diagonal approach. On the other hand, the combination based on VC estimation shows large differences among the VCs and exhibits a comparable scaling of formal errors. Thus, for the combination of troposphere parameters a combination of the two extensions of the stochastic model is recommended.
|
|
| 8. |
|
|
| 9. |
- Im, Annie, et al.
(författare)
-
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
- 2020
-
Ingår i: Biology of blood and marrow transplantation. - : Elsevier BV. - 1083-8791 .- 1523-6536. ; 26:8, s. 1459-1468
-
Tidskriftsartikel (refereegranskat)abstract
- Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. Data from the Center for International Blood and Marrow Transplant Research on adult patients with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, or chronic myeloid leukemia who underwent PTCy-based haplo-HCT (2013 to 2016) were analyzed and categorized into 4 groups based on myeloablative (MA) or reduced-intensity conditioning (RIC) and bone marrow (BM) or peripheral blood (PB) graft source. In total, 646 patients were identified (MA-BM = 79, MA-PB = 183, RIC-BM = 192, RIC-PB = 192). The incidence of grade 2 to 4 acute GVHD at 6 months was highest in MA-PB (44%), followed by RIC-PB (36%), MA-BM (36%), and RIC-BM (30%) (P = .002). The incidence of chronic GVHD at 1 year was 40%, 34%, 24%, and 20%, respectively (P < .001). In multivariable analysis, there was no impact of stem cell source or conditioning regimen on grade 2 to 4 acute GVHD; however, older donor age (30 to 49 versus <29 years) was significantly associated with higher rates of grade 2 to 4 acute GVHD (hazard ratio [HR], 1.53; 95% confidence interval [CI], 1.11 to 2.12; P = .01). In contrast, PB compared to BM as a stem cell source was a significant risk factor for the development of chronic GVHD (HR, 1.70; 95% CI, 1.11 to 2.62; P = .01) in the RIC setting. There were no differences in relapse or overall survival between groups. Donor age and graft source are risk factors for acute and chronic GVHD, respectively, after PTCy-based haplo-HCT. Our results indicate that in RIC haplo-HCT, the risk of chronic GVHD is higher with PB stem cells, without any difference in relapse or overall survival.
|
|
| 10. |
- Petrachenko, Bill, et al.
(författare)
-
Design Aspects of the VLBI2010 System
- 2009
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- This report summarizes the progress made in developing the next generation VLBI, dubberd the VLBI2010 system. The VLBI2010 Committee of the International Service for Geodesy and Astrometry (IVS) worked on the design aspects of the new system.…
|
|
| 11. |
- Petrachenko, Bill, et al.
(författare)
-
Progress Report of the IVS VLBI2010 Committee
- 2009
-
Ingår i: In: International VLBI Service for Geodesy and Astrometry 2008 Annual Report, edited by D. Behrend and K. Baver. ; NASA/TP-2009-214183, 2009, s. 13-67
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 12. |
- Pinheiro Astone, Daniel Augusto, 1986-
(författare)
-
Living as a commodity : Law, exploitation and the trade on human lives
- 2024
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- This dissertation investigates the role of the law in affording the conditions of possibility for exploitation to install and reproduce itself in the context of contemporary capitalism. It engages with the dialectical incompossibility of some of the key normative assumptions embedded in the law and the economy vis-à-vis their phenomenological consequences. With support from Niklas Luhmann’s systems theory, the dissertation relies on two main examples – patents on essential medicines and labour exploitation – to examine the tension between expropriation and accumulation. It advances the novel concept of “ablegality” as a register for the remainder that every phenomenological-hermeneutic operation will inevitably generate as the potentiality that accompanies all phenomenological reduction. The principal contribution made through this dissertation lies in articulating the role of the invisibilised side of legal operations as drivers for exploitation and, ultimately, for injustice to manifest legally.
|
|
| 13. |
- Qayed, Muna, et al.
(författare)
-
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia : Implications for Prophylaxis
- 2018
-
Ingår i: Biology of blood and marrow transplantation. - : Elsevier BV. - 1083-8791 .- 1523-6536. ; 24:3, s. 521-528
-
Tidskriftsartikel (refereegranskat)abstract
- Relapse remains the major cause of mortality after hematopoietic cell transplantation (HCT) for pediatric acute leukemia. Previous research has suggested that reducing the intensity of calcineurin inhibitor-based graft-versus-host disease (GVHD) prophylaxis may be an effective strategy for abrogating the risk of relapse in pediatric patients undergoing matched sibling donor (MSD) HCT. We reasoned that the benefits of this strategy could be maximized by selectively applying it to those patients least likely to develop GVHD. We conducted a study of risk factors for GVHD, to risk-stratify patients based on age. Patients age <18 years with leukemia who received myeloablative, T cell-replete MSD bone marrow transplantation and calcineurin inhibitor-based GVHD prophylaxis between 2000 and 2013 and were entered into the Center for International Blood and Marrow Transplant Research registry were included. The cumulative incidence of grade II-IV acute GVHD (aGVHD) was 19%, that of grade II-IV aGVHD 7%, and that of chronic GVHD (cGVHD) was 16%. Compared with age 13 to 18 years, age 2 to 12 years was associated with a lower risk of grade II-IV aGVHD (hazard ratio [HR], .42; 95% confidence interval [CI], .26 to .70; P = .0008), grade II-IV aGVHD (HR, .24; 95% CI, .10 to .56; P = .001), and cGVHD (HR, .32; 95% CI, .19 to .54; P < .001). Compared with 2000-2004, the risk of grade II-IV aGVHD was lower in children undergoing transplantation in 2005-2008 (HR, .36; 95% CI, .20 to .65; P = .0007) and in 2009-2013 (HR, .24; 95% CI. .11 to .53; P = .0004). Similarly, the risk of grade III-IV aGVHD was lower in children undergoing transplantation in 2005-2008 (HR, .23; 95% CI, .08 to .65; P = .0056) and 2009-2013 (HR, .16; 95% CI, .04 to .67; P = .0126) compared with those doing so in 2000-2004. We conclude that aGVHD rates have decreased significantly over time, and that children age 2 to 12 years are at very low risk for aGVHD and cGVHD. These results should be validated in an independent analysis, because these patients with high-risk malignancies may be good candidates for trials of reduced GVHD prophylaxis.
|
|
| 14. |
- Saad, Ayman, et al.
(författare)
-
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
- 2019
-
Ingår i: Biology of blood and marrow transplantation. - : ELSEVIER SCIENCE INC. - 1083-8791 .- 1523-6536. ; 25:9, s. 1875-1883
-
Tidskriftsartikel (refereegranskat)abstract
- Data on whether the T cell dose of allogeneic peripheral blood stem cell (PBSC) products influences transplantation outcomes are conflicting. Using the Center for International Blood and Marrow Transplant Research database, we identified 2736 adult patients who underwent first allogeneic PBSC transplantation for acute leukemia or myelodysplastic syndrome between 2008 and 2014 using an HLA-matched sibling donor (MSD) or an 8/8-matched unrelated donor (MUD). We excluded ex vivo and in vivo T cell-depleted transplantations. Correlative analysis was performed between CD3(+) T cell dose and the risk of graft-versus-host-disease (GVHD), relapse, nonrelapse mortality (NRM), disease-free survival (DFS), and overall survival (OS). Using maximum likelihood estimation, we identified CD3(+) T cell dose cutoff that separated the risk of acute GVHD (aGVHD) grade II-IV in both the MSD and MUD groups. A CD3(+) T cell dose cutoff of 14 x 10(7) cells/kg identified MSD/low CD3(+) (n = 223) and MSD/high CD3(+) (n = 1214), and a dose of 15 x 107 cells/kg identified MUD/low (n = 197) and MUD/high CD3(+) (n = 1102). On univariate analysis, the MSD/high CD3(+) group had a higher cumulative incidence of day +100 aGVHD grade II-IV compared with the MSD/low CD3(+) group (33% versus 25%; P=.009). There were no differences between the 2 groups in engraftment rate, risk of aGVHD grade III-IV or chronic GVHD (cGVHD), NRM, relapse, DFS, or OS. The MUD/high CD3(+) group had a higher cumulative incidence of day +100 aGVHD grade II-IV compared with the MUD/low CD3(+) group (49% versus 41%; P=.04). There were no differences between the 2 groups in engraftment rate, risk of severe aGVHD or cGVHD, NRM, relapse, DFS, or OS. Multivariate analysis of the MSD and MUD groups failed to show an association between CD3(+) T cell dose and the risk of either aGVHD grade II-IV (P=.10 and .07, respectively) or cGVHD (P = .80 and .30, respectively). Subanalysis of CD4(+) T cells, CD8(+) T cells, and CD4+/CD8+ ratio failed to identify cutoff values predictive of transplantation outcomes; however, using the log-rank test, the sample size was suboptimal for identifying a difference at this cutoff cell dose. In this registry study, the CD3(+) T cell dose of PBSC products did not influence the risk of aGVHD or cGVHD or other transplantation outcomes when using an MSD or an 8/8-matched MUD. Subset analyses of CD4(+) and CD8(+) T cell doses were not possible given our small sample size. (C) 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
|
|
| 15. |
- Thomas, Cynthia C., et al.
(författare)
-
Performance of the IVS R1 and R4 sessions
- 2024
-
Ingår i: Advances in Space Research. - 1879-1948 .- 0273-1177. ; 73:1, s. 317-336
-
Tidskriftsartikel (refereegranskat)abstract
- The International VLBI Service for Geodesy and Astrometry (IVS) has observed the weekly IVS-R1 (R1) and IVS-R4 (R4) series of sessions since 2002. These regular series are generally stable in the sense that the networks were designed to be similar from week to week. The uniformity of these series has allowed researchers to conduct many scientific investigations. The IVS also observes with other networks that allow continued sampling of data from all VLBI stations, but the R1 and R4 observing sessions are a dominant part of overall VLBI observing accounting for 1841 sessions out of a total of 3129 24-hour sessions from 2002.0 to 2020.0 (where the last R1 and R4 in 2019 was on December 30 and December 26, respectively). In this paper, we investigate the evolution of these series in terms of their observing networks. We also discuss the construction of the R1 and R4 networks and the scheduling of these sessions. The performance of these networks in terms of the formal precision of polar motion have improved by factors of 2–3 over the period from 2002.0 to 2018.0. UT1 precision improved by a factor of about 1.2–1.5. The main reason for this improvement is the increased size of the networks. We also discuss the effect on this improvement arising from changes in the data rate and the number of observed sources. There is some degradation in performance after 2018 that is most likely due to a decline in the number of available network stations.
|
|
| 16. |
|
|
